Seller record · Research vendor

Geo Peptides

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed anywhere on the site, and a footer notice sells every product for research and development only. 3 more criteria also fail; see the table below.

At a glance

Geo PeptidesResearch vendor

4/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides including tirzepatide and GLP-2, SARMs, and 3 more
FDA letters: None on file

Visit Geo Peptides See all eight dispositions

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide and chemical seller offering GLP-1 analogues, SARMs and bulk compounds. Its test results page links laboratory reports that print a purity figure and no lot number.

Operating entity No legal entity name is printed in the footer, the about page, the terms and conditions or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Geo Peptides' terms and conditions
S2	Prescription gating	FAIL	Geo Peptides' checkout
S3	Pharmacy identification	FAIL	Geo Peptides' about page
S4	Compounding disclosure	PASS	Geo Peptides' about page
S5	Analytical documentation	PASS	Geo Peptides' posted image
S6	Business address	FAIL	Geo Peptides' about page
S7	Price disclosure	PASS	Geo Peptides' website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician evaluation is claimed anywhere on the site, and a footer notice sells every product for research and development only.Source: Geo Peptides' terms and conditions.

S2FAILA guest checkout collects a shipping address and states that an account may be created after checkout, starting from the tirzepatide page at 249.99 dollars.Source: Geo Peptides' checkout.

S3FAILNo pharmacy is named anywhere on the site, and a footer notice states that the seller is not a compounding pharmacy under section 503A.Source: Geo Peptides' about page.

S4PASSThe seller offers no compounded drug, and a footer notice on every page states that the products have not been evaluated by the Food and Drug Administration.Source: Geo Peptides' about page.

S5PASSThe test results page links public reports from Crestview Analytical, among them retatrutide 10 mg at 98.919 percent purity, and the reports print no lot number.Source: Geo Peptides' posted image.

S6FAILThe footer, about, questions, terms and privacy pages print an email address and shipping guidance and no street address anywhere.Source: Geo Peptides' about page.

S7PASSThe tirzepatide page prints 249.99 dollars and 299.99 dollars across two sizes with no account required, and the catalog prints figures from 29.99 dollars upward.Source: Geo Peptides' website.

S8PASSNo FDA warning letter names the storefront, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including tirzepatide and GLP-2, SARMs, bulk chemicals and peptides, research liquids, retatrutide, sold as a blend with IGF-1 LR3.

Other sellers of the same products

Who sells tirzepatide Who sells retatrutide

Visit Geo Peptides

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.